Trial Profile
The Highly Sensitized Patients: Effects of Mycophenolate Mofetil On Anti-HLA Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms HICAD-MMF
- 06 Apr 2010 Actual patient number (45) added as reported by ClinicalTrials.gov.
- 10 Oct 2009 New trial record